Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Account Payables: 2021-2025

Historic Change in Account Payables for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$18.2 million.

  • Roivant Sciences' Change in Account Payables fell 58.45% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.5 million, marking a year-over-year decrease of 8.22%. This contributed to the annual value of -$18.2 million for FY2025, which is 180.09% down from last year.
  • Latest data reveals that Roivant Sciences reported Change in Account Payables of -$18.2 million as of FY2025, which was down 180.09% from $22.7 million recorded in FY2024.
  • In the past 5 years, Roivant Sciences' Change in Account Payables ranged from a high of $22.7 million in FY2024 and a low of -$18.2 million during FY2025.
  • Its 3-year average for Change in Account Payables is $3.0 million, with a median of $4.4 million in 2023.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 420.39% in 2024, then crashed by 180.09% in 2025.
  • Roivant Sciences' Change in Account Payables (Yearly) stood at $3.8 million in 2021, then surged by 310.53% to $15.4 million in 2022, then crashed by 71.70% to $4.4 million in 2023, then surged by 420.39% to $22.7 million in 2024, then plummeted by 180.09% to -$18.2 million in 2025.